Nepsis Inc. Amgen Inc Transaction History

Nepsis Inc.

$289 Million
Q2 2025

A detailed history of Nepsis Inc. transactions in Amgen Inc stock. As of the latest transaction made, Nepsis Inc. holds 55,998 shares of AMGN stock, worth $16.1 Million. This represents 5.4% of its overall portfolio holdings.

Number of Shares

55,998

Previous 68,752 18.55%

Holding current value

$16.1 Million

Previous $21.4 Million 27.0%

% of portfolio

5.4%

Previous 6.2%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 14, 2025	SELL	$262.28 - $309.85 $3.35 Million - $3.95 Million	-12,754 Reduced 18.55%	55,998 $15.6 Million
Q1 2025 Apr 15, 2025	BUY	$258.59 - $327.36 $718,880 - $910,060	2,780 Added 4.21%	68,752 $21.4 Million
Q4 2024 Jan 21, 2025	BUY	$258.78 - $328.31 $1.62 Million - $2.05 Million	6,257 Added 10.48%	65,972 $17.2 Million
Q3 2024 Oct 18, 2024	BUY	$309.38 - $337.38 $1.16 Million - $1.26 Million	3,735 Added 6.67%	59,715 $19.2 Million
Q2 2024 Jul 15, 2024	BUY	$262.75 - $319.31 $174,203 - $211,702	663 Added 1.2%	55,980 $17.5 Million
Q1 2024 Apr 12, 2024	SELL	$268.87 - $324.56 $375,611 - $453,410	-1,397 Reduced 2.46%	55,317 $15.7 Million
Q4 2023 Jan 18, 2024	SELL	$255.7 - $288.46 $262,859 - $296,536	-1,028 Reduced 1.78%	56,714 $16.3 Million
Q3 2023 Oct 13, 2023	BUY	$218.65 - $271.46 $4.51 Million - $5.6 Million	20,630 Added 55.59%	57,742 $15.5 Million
Q2 2023 Jul 17, 2023	BUY	$214.27 - $253.37 $7.95 Million - $9.4 Million	37,112 New	37,112 $8.24 Million

Others Institutions Holding AMGN

# of Institutions

3,277

Shares Held

427M

Call Options Held

7.33M

Put Options Held

7.41M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nepsis Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nepsis Inc. with notifications on news.

Account